Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Denis

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Therapie|December 28, 2022
Antoine Pariente, Joëlle Micallef, Amir Lahouegue, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 12, 2019
Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trialBenjamin Lacas, Olivier Bouché, Pierre-Luc Etienne, et al.
Therapie|January 26, 2022
Prevention of risks associated with inappropriate use/unnecessary consumption of medicinesJean-Luc Cracowski, Sophie Muller, Isabelle Anglade, et al.
Therapie|January 24, 2022
Jean-Luc Cracowski, Sophie Muller, Isabelle Anglade, et al.
The Lancet. Oncology|September 10, 2011
Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trialMichel Ducreux, David Malka, Jean Mendiboure, et al.
Endoscopy International Open|November 18, 2021
COVID-19 and gastrointestinal endoscopy in France: from the first to the second waveMaximilien Barret, Arthur Belle, David Bernardini, et al.
Endoscopy|June 20, 2020
Impact of the COVID-19 pandemic on gastrointestinal endoscopy activity in FranceArthur Belle, Maximilien Barret, David Bernardini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trialDidier Peiffert, Laetitia Tournier-Rangeard, Jean-Pierre Gérard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2Jean-Pierre Gérard, David Azria, Sophie Gourgou-Bourgade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancerJean-Pierre Gérard, David Azria, Sophie Gourgou-Bourgade, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Therapie|December 28, 2022
Antoine Pariente, Joëlle Micallef, Amir Lahouegue, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 12, 2019
Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trialBenjamin Lacas, Olivier Bouché, Pierre-Luc Etienne, et al.
Therapie|January 26, 2022
Prevention of risks associated with inappropriate use/unnecessary consumption of medicinesJean-Luc Cracowski, Sophie Muller, Isabelle Anglade, et al.
Therapie|January 24, 2022
Jean-Luc Cracowski, Sophie Muller, Isabelle Anglade, et al.
The Lancet. Oncology|September 10, 2011
Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trialMichel Ducreux, David Malka, Jean Mendiboure, et al.
Endoscopy International Open|November 18, 2021
COVID-19 and gastrointestinal endoscopy in France: from the first to the second waveMaximilien Barret, Arthur Belle, David Bernardini, et al.
Endoscopy|June 20, 2020
Impact of the COVID-19 pandemic on gastrointestinal endoscopy activity in FranceArthur Belle, Maximilien Barret, David Bernardini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trialDidier Peiffert, Laetitia Tournier-Rangeard, Jean-Pierre Gérard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2Jean-Pierre Gérard, David Azria, Sophie Gourgou-Bourgade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancerJean-Pierre Gérard, David Azria, Sophie Gourgou-Bourgade, et al.
Pageof 6